Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001401145 | SCV001602966 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2023-09-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001401145 | SCV002083869 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2020-01-14 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003936216 | SCV004756571 | likely benign | AIRE-related disorder | 2019-06-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |